HEADER OXIDOREDUCTASE 12-FEB-01 1I30 TITLE E. COLI ENOYL REDUCTASE +NAD+SB385826 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ENOYL REDUCTASE, ACP, ANTIBIOTIC, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.SEEFELD,W.H.MILLER,D.J.PAYNE,C.A.JANSON,X.QIU REVDAT 4 07-FEB-24 1I30 1 REMARK REVDAT 3 13-JUL-11 1I30 1 VERSN REVDAT 2 24-FEB-09 1I30 1 VERSN REVDAT 1 12-FEB-02 1I30 0 JRNL AUTH M.A.SEEFELD,W.H.MILLER,K.A.NEWLANDER,W.J.BURGESS,D.J.PAYNE, JRNL AUTH 2 S.F.RITTENHOUSE,T.D.MOORE,W.E.DEWOLF,P.M.KELLER,X.QIU, JRNL AUTH 3 C.A.JANSON,K.VAIDYA,A.P.FOSBERRY,M.G.SMYTH,D.D.JAWORSKI, JRNL AUTH 4 C.SLATER-RADOSTI,W.F.HUFFMAN JRNL TITL INHIBITORS OF BACTERIAL ENOYL ACYL CARRIER PROTEIN REDUCTASE JRNL TITL 2 (FABI): 2,9-DISUBSTITUTED JRNL TITL 3 1,2,3,4-TETRAHYDROPYRIDO[3,4-B]INDOLES AS POTENTIAL JRNL TITL 4 ANTIBACTERIAL AGENTS. JRNL REF BIOORG.MED.CHEM.LETT. V. 11 2241 2001 JRNL REFN ISSN 0960-894X JRNL PMID 11527706 JRNL DOI 10.1016/S0960-894X(01)00404-8 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 18929 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : 5% REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 925 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3676 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 337 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1I30 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-01. REMARK 100 THE DEPOSITION ID IS D_1000012839. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23223 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.0 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.07300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 108.61000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 217.22000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 162.91500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 271.52500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.30500 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 108.61000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 217.22000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 271.52500 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 162.91500 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 54.30500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 20570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -123.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 39.74500 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 68.84036 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 271.52500 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1681 LIES ON A SPECIAL POSITION. REMARK 375 HOH B1553 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LEU A 195 REMARK 465 ALA A 196 REMARK 465 ALA A 197 REMARK 465 SER A 198 REMARK 465 GLY A 199 REMARK 465 ILE A 200 REMARK 465 LYS A 201 REMARK 465 ASP A 202 REMARK 465 GLU A 258 REMARK 465 LEU A 259 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 LYS A 262 REMARK 465 MET B 1001 REMARK 465 LEU B 1195 REMARK 465 ALA B 1196 REMARK 465 ALA B 1197 REMARK 465 SER B 1198 REMARK 465 GLY B 1199 REMARK 465 ILE B 1200 REMARK 465 LYS B 1201 REMARK 465 ASP B 1202 REMARK 465 GLU B 1258 REMARK 465 LEU B 1259 REMARK 465 GLU B 1260 REMARK 465 LEU B 1261 REMARK 465 LYS B 1262 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 204 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 205 CG CD CE NZ REMARK 470 ARG B1204 CG CD NE CZ NH1 NH2 REMARK 470 LYS B1205 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 1562 O HOH B 1562 10665 1.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B1137 C - N - CA ANGL. DEV. = -10.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 43 -17.89 -48.49 REMARK 500 LYS A 45 -92.08 -49.25 REMARK 500 LEU A 100 47.90 -98.60 REMARK 500 ASN A 155 -26.98 70.64 REMARK 500 ASN A 157 -122.86 38.26 REMARK 500 ARG A 218 148.79 -173.13 REMARK 500 SER A 237 31.96 -99.04 REMARK 500 VAL B1065 -4.49 -56.21 REMARK 500 PHE B1094 139.30 -170.44 REMARK 500 LEU B1100 35.67 -95.92 REMARK 500 ASN B1155 -18.37 67.38 REMARK 500 ASN B1157 -127.29 33.83 REMARK 500 ARG B1193 84.89 -66.55 REMARK 500 VAL B1247 65.91 -115.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 826 A 302 REMARK 610 826 B 1302 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 826 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 826 B 1302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C14 RELATED DB: PDB REMARK 900 1C14 IS CRYSTAL STRUCTURE OF E. COLI ENOYL REDUCTASE-NAD+-TRICLOSAN REMARK 900 COMPLEX REMARK 900 RELATED ID: 1I2Z RELATED DB: PDB REMARK 900 1I2Z IS E. COLI ENOYL REDUCTASE IN COMPLEX WITH NAD AND BRL-12654 DBREF 1I30 A 1 262 UNP P29132 FABI_ECOLI 0 261 DBREF 1I30 B 1001 1262 UNP P29132 FABI_ECOLI 0 261 SEQRES 1 A 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 A 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 A 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 A 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 A 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 A 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 A 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 A 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 A 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 A 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 A 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 A 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 A 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 A 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 A 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 A 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 A 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 A 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 A 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 A 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 A 262 LEU LYS SEQRES 1 B 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 B 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 B 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 B 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 B 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 B 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 B 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 B 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 B 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 B 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 B 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 B 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 B 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 B 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 B 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 B 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 B 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 B 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 B 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 B 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 B 262 LEU LYS HET NAD A 301 44 HET 826 A 302 10 HET NAD B1301 44 HET 826 B1302 10 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 826 1,3,4,9-TETRAHYDRO-2-(HYDROXYBENZOYL)-9-[(4- HETNAM 2 826 HYDROXYPHENYL)METHYL]-6-METHOXY-2H-PYRIDO[3,4-B]INDOLE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 826 2(C25 H22 N2 O3) FORMUL 7 HOH *337(H2 O) HELIX 1 1 SER A 19 GLU A 31 1 13 HELIX 2 2 ASN A 41 LYS A 43 5 3 HELIX 3 3 LEU A 44 LEU A 55 1 12 HELIX 4 4 GLU A 67 TRP A 82 1 16 HELIX 5 5 PRO A 96 ASP A 101 5 6 HELIX 6 6 ASP A 103 VAL A 108 1 6 HELIX 7 7 THR A 109 SER A 121 1 13 HELIX 8 8 SER A 121 ARG A 132 1 12 HELIX 9 9 TYR A 146 GLU A 150 5 5 HELIX 10 10 ASN A 157 GLY A 178 1 22 HELIX 11 11 PHE A 203 THR A 214 1 12 HELIX 12 12 THR A 221 CYS A 233 1 13 HELIX 13 13 SER A 234 ALA A 238 5 5 HELIX 14 14 GLY A 250 ALA A 254 5 5 HELIX 15 15 SER B 1019 GLU B 1031 1 13 HELIX 16 16 LEU B 1044 LEU B 1055 1 12 HELIX 17 17 GLU B 1067 GLY B 1079 1 13 HELIX 18 18 PRO B 1096 ASP B 1101 5 6 HELIX 19 19 ASP B 1103 VAL B 1108 1 6 HELIX 20 20 THR B 1109 SER B 1121 1 13 HELIX 21 21 SER B 1121 ARG B 1132 1 12 HELIX 22 22 TYR B 1146 GLU B 1150 5 5 HELIX 23 23 ASN B 1157 GLY B 1178 1 22 HELIX 24 24 PHE B 1203 THR B 1214 1 12 HELIX 25 25 THR B 1221 CYS B 1233 1 13 HELIX 26 26 SER B 1234 ALA B 1238 5 5 HELIX 27 27 GLY B 1250 ALA B 1254 5 5 SHEET 1 A 7 VAL A 60 GLN A 62 0 SHEET 2 A 7 GLU A 34 TYR A 39 1 O PHE A 37 N LEU A 61 SHEET 3 A 7 ARG A 8 VAL A 11 1 N ILE A 9 O GLU A 34 SHEET 4 A 7 PHE A 88 HIS A 90 1 N VAL A 89 O LEU A 10 SHEET 5 A 7 SER A 139 SER A 145 1 O LEU A 142 N HIS A 90 SHEET 6 A 7 VAL A 182 ALA A 189 1 O ARG A 183 N LEU A 141 SHEET 7 A 7 VAL A 244 VAL A 247 1 O VAL A 245 N SER A 188 SHEET 1 B 7 VAL B1060 GLN B1062 0 SHEET 2 B 7 GLU B1034 TYR B1039 1 O PHE B1037 N LEU B1061 SHEET 3 B 7 ARG B1008 VAL B1011 1 N ILE B1009 O GLU B1034 SHEET 4 B 7 PHE B1085 HIS B1090 1 N ASP B1086 O ARG B1008 SHEET 5 B 7 LEU B1135 SER B1145 1 N ASN B1136 O PHE B1085 SHEET 6 B 7 VAL B1182 ALA B1189 1 O ARG B1183 N LEU B1141 SHEET 7 B 7 VAL B1244 VAL B1247 1 O VAL B1245 N SER B1188 SITE 1 AC1 20 GLY A 13 ALA A 15 SER A 19 ILE A 20 SITE 2 AC1 20 GLN A 40 CYS A 63 ASP A 64 VAL A 65 SITE 3 AC1 20 SER A 91 ILE A 92 LEU A 144 SER A 145 SITE 4 AC1 20 LYS A 163 ALA A 189 GLY A 190 PRO A 191 SITE 5 AC1 20 ILE A 192 THR A 194 826 A 302 HOH A1431 SITE 1 AC2 24 GLY B1013 ALA B1015 SER B1019 ILE B1020 SITE 2 AC2 24 GLN B1040 LEU B1044 CYS B1063 ASP B1064 SITE 3 AC2 24 VAL B1065 SER B1091 ILE B1092 GLY B1093 SITE 4 AC2 24 ILE B1119 LEU B1144 SER B1145 LYS B1163 SITE 5 AC2 24 ALA B1189 GLY B1190 PRO B1191 ILE B1192 SITE 6 AC2 24 THR B1194 826 B1302 HOH B1403 HOH B1410 SITE 1 AC3 5 TYR A 156 PRO A 191 PHE A 203 MET A 206 SITE 2 AC3 5 NAD A 301 SITE 1 AC4 5 TYR B1156 PRO B1191 PHE B1203 MET B1206 SITE 2 AC4 5 NAD B1301 CRYST1 79.490 79.490 325.830 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012580 0.007263 0.000000 0.00000 SCALE2 0.000000 0.014526 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003069 0.00000